Patrick Schwartz, MD, PhD retweetledi

Very good read & practical article: Mounting data suggest early-day administration of checkpoint inhibitors may be linked to better outcomes!
@JCOOP_ASCO
ascopubs.org/doi/10.1200/OP…
Stay tuned—our @MayoCancerCare analysis on timing in GI cancer pts will be presented in one week at #ASCOGI26 (#GI26)! #GIonc #Immunotherapy 🎯
English



















